Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-25 @ 9:50 PM
Study NCT ID:
NCT03532451
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2018-05-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Sponsor:
PrECOG, LLC.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-22
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-05
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-10
First Submit QC Date:
None
Study First Post Date:
2018-05-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-06-21
Results First Submit QC Date:
None
Results First Post Date:
2021-09-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-16
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL